721 followers
#HealthEconJA Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events https://t.co/SzQrqR8hcT
#HealthEconJA Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events https://t.co/SzQrqR8hcT